Yun Zhang
Director/Miembro de la Junta en CHINA INTERNATIONAL HOLDINGS LIMITED .
Perfil
Yun Zhang is currently an Independent Director at China International Holdings Ltd., a Director at Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd., and a Founding Partner at Shenzhen Riverbed Yucheng Private Equity Investment Enterprise.
Previously, Mr. Zhang worked as a Director at Beijing Tivani Medical Technology Co. Ltd.
Mr. Zhang completed their graduate degree at Peking University and their undergraduate degree at Sun Yat-Sen University.
Cargos activos de Yun Zhang
| Empresas | Cargo | Inicio |
|---|---|---|
| CHINA INTERNATIONAL HOLDINGS LIMITED | Director/Miembro de la Junta | 01/12/2023 |
Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd.
 Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. was founded in 2010 and is based in Taizhou, China. The Chinese company focuses on the exploration and research of high-barrier generic drugs for perioperative and tumor pain management, as well as the development of improved new drugs with significant technological advancements and application prospects, using leading global drug delivery technologies to provide patients with more and better drug choices. The company also produces a trademarked drug called Pusiding, which is a combination of hydrocodone bitartrate and acetaminophen used for pain relief. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Yun Zhang.
| Empresas | Cargo | Fin |
|---|
Formación de Yun Zhang.
| Peking University | Graduate Degree |
| Sun Yat-Sen University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CHINA INTERNATIONAL HOLDINGS LIMITED | Finance |
| Empresas privadas | 1 |
|---|---|
Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd.
Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. was founded in 2010 and is based in Taizhou, China. The Chinese company focuses on the exploration and research of high-barrier generic drugs for perioperative and tumor pain management, as well as the development of improved new drugs with significant technological advancements and application prospects, using leading global drug delivery technologies to provide patients with more and better drug choices. The company also produces a trademarked drug called Pusiding, which is a combination of hydrocodone bitartrate and acetaminophen used for pain relief. | Health Technology |
- Bolsa de valores
- Insiders
- Yun Zhang
